3 Biotech Stocks That Could Be Millionaire-Makers: May Edition

As we delve deeper into 2024, biotech stocks are commanding the attention of growth-focused investors. Despite facing volatility and regulatory challenges in recent years, biotech is poised for a resurgence. Breakthroughs in personalized medicine and gene editing technologies are driving biotech forward.The global biotechnology market was valued at $1.0 trillion in 2022 and is projected to reach$3.6 trillion by 2032. Increasing demand for personalized medicine and advancements in genetic engineering will d ...